Healthcare & Life Sciences
CORXEL Pharmaceuticals
United Stateswww.corxelbio.com/en/
CORXEL Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About CORXEL Pharmaceuticals
CORXEL Pharmaceuticals is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
CORXEL Pharmaceuticals is a biopharmaceutical company developing therapies targeting cardiometabolic and cardiovascular diseases, including hypertrophic cardiomyopathy and heart failure, with operations in the US and China.
Explore CORXEL Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.